chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lymph node pain; Axilla and chest swelling; Chest pain; Chills; Fatigue; Malaise; This is a spontaneous report from a contactable other healthcare professional, the patient. A 38-years old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 2613), via an unspecified route of administration in the left arm on 24Mar2021 at 08:00 (at the age of 38-years old) as a single dose for COVID-19 Immunisation. Medical history included as healthy patient. The patient was not allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within 2 weeks of vaccination as Concomitant medication. On 25Mar2021 at 02:15, the patient experienced lymph node, axilla and chest swelling, chest pain, chills, fatigue and malaise. The patient did not receive any treatment for event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lymph node, axilla and chest swelling, chest pain, chills, fatigue and malaise were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
After the second Moderna shot I had three days of chills and fever. Once that was done I noticed small painful red dots around my eyes that would get worse then subside. I thought it was eczema so I put moisturizer on it but it didn't go away. Then about a month after the second shot I felt terrible again and had another day of fever and chills. I went and got a covid test which was negative. Then in the beginning of July I once again had fever and chills. I also had pain and itching in my vagina which I thought was a yeast infection. The fever wasn't going away so I went to an urgent care and was diagnosed with a UTI. I began the antibiotics but my fever was getting worse so I went to the ER. It turned out to be a herpes outbreak, the first I ever had. That's what was causing the fever and chills. When I started taking the Valtrex the rash that had still been around my eyes finally went away. I believe that the rash was also herpes. I have been taking Valtrex since July and the herpes in my vagina and inside my upper and lower lips in my mouth is still there. It no longer hurts but I can see the raised strips of skin in my mouth and the red streaks in my vagina. It feels like this is never going away and I am worried about getting the Moderna booster in case it would make it all flare up  even worse than it is now.
It started like a cold with sore throat. Then nasal congestion, the next day I felt exhausted. The next day I had a terrible headache. The next couple of days felt better but I still had body aches. I only ran a fever on the first day with a sore throat, the fever did not exceed over 100. The last day I experienced diarrhea. I did not lose smell or taste. I took BENADRYL, NYQUIL and acetaminophen.
No adverse effect reported; the patient was inadvertently administered a dose of PROQUAD; This spontaneous report was received from the vaccine coordinator and refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions and historical drugs was not provided.  On 24-SEP-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(rha)(PROQUAD) (strength, dose, route and anatomical location were not provided) for prophylaxis. The following lot numbers were reported: lot # R030805 with expiration date on 22-APR-2020 and lot # S003326 with expiration date on 02-AUG-2020.  The vaccine was exposed to a temperature of 27.1 degrees fahrenheit during 40 minutes. There was not previous temperature excursion. It was reported that digital data logger was involved. No adverse effects were reported. The vaccine was reconstituted with properly sterile diluent.
body aches; chills; chest pains; headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Feb-2021 and was forwarded to Moderna on 05-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), CHILLS (chills), CHEST PAIN (chest pains) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for an unknown indication.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), CHILLS (chills), CHEST PAIN (chest pains) and HEADACHE (headache). At the time of the report, PAIN (body aches), CHILLS (chills), CHEST PAIN (chest pains) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment includes Tylenol and Advil. Patient was taking Centamin previously but stopped a few month ago.
HERNIA ON CHEST; FEELING AWFUL; PAIN FROM THE HERNIA; High blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of HERNIA (HERNIA ON CHEST), FEELING ABNORMAL (FEELING AWFUL), HERNIA PAIN (PAIN FROM THE HERNIA) and HYPERTENSION (High blood pressure) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form, dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. and ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced HERNIA (HERNIA ON CHEST), FEELING ABNORMAL (FEELING AWFUL), HERNIA PAIN (PAIN FROM THE HERNIA) and HYPERTENSION (High blood pressure). At the time of the report, HERNIA (HERNIA ON CHEST), HERNIA PAIN (PAIN FROM THE HERNIA) and HYPERTENSION (High blood pressure) had not resolved and FEELING ABNORMAL (FEELING AWFUL) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: High.         No concomitant and treatment were reported This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
Patient has what appears to be an auto-inoculation site on her right ear approximately 5 cm with whitish blister and scab formation in center.
Last night (4/15/14), he woke up from sleep screaming, and had a convulsion lasting about 5 minutes. He was limp and lethargic for about 10 minutes postictally. Mom called rescue when she found him seizing and by the time paramedics arrived, the seizure had abated. He was taken to the ER, and evaluated. By the time he arrived at the ER, he was awake and crying. They dx Febrile Seizure, and OM, but did not treat the OM. Fever for 2 days and cough. Scheduled for ear tubes 4/23/14.
Sweating after second dose; a bit of nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating after second dose), NAUSEA (a bit of nausea) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweating after second dose), NAUSEA (a bit of nausea) and HEADACHE (headache). At the time of the report, HYPERHIDROSIS (Sweating after second dose), NAUSEA (a bit of nausea) and HEADACHE (headache) outcome was unknown. Not Provided          No concomitant details were provided No treatment details were provided
Narrative:  Patient received Janssen Covid vaccine on 4/10/21. There are no CPRS notes or scanned records from that time until his date of death on 4/28/21 to indicate what happened. He was contacted on 4/20/21 about potential side effects and per notes, no issues were reported at that time. Time from vaccine to date of death was 18 days. No autopsy report available.
Tetanus vac on 9/19/02. On 9/26/02 1 1/2" red raised, warm area on L arm. Next day or so about 4" or 5" spot on arm showed nurse practitioner on 26th. Two days later hives began. Was seen on 10/2 fo classic case of hives.
4.2 x 4.2 area of erythema, swelling, induration very low on lt upper arm almost in area of bicep;sx lasted 48hr;
MISSED THE DELTOID; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-MAR-2021, the subject experienced missed the deltoid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of missed the deltoid was not reported. This report was non-serious.
Mother told provider that child had a fever and wasn't eating as much. Pt did have a Temp of 102 degrees.
Systemic: Allergic: Rash Generalized-Medium, Additional Details: Patient had rash for few days after vaccine- disappeared after some cream and steroid injection.
This spontaneous report was received from a Certified Medical Assistant, referring to an unspecified number of patients of unknown demographics. No medical history nor concurrent conditions were reported. On an unknown date, the unspecified number of patients were vaccinated with improperly stored doses of GARDASIL (lot # K011562, expiration date 08-APR-2017) (strength, dose and route were not reported). No concomitant medications were reported. No adverse effects were reported. No product quality complaints were reported. This is one of three reports from the same source. Additional information has been requested.
Daily nausea and vomiting, headaches, fatigue, body aches, rash, break thru menstral bleeding, dizzy.
prickly sensation in both arms; This case was reported by a consumer via call center representative and described the occurrence of tingling sensation in a 79-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd July 2020, the patient received the 1st dose of Shingrix. In July 2020, less than a week after receiving Shingrix, the patient experienced tingling sensation. On an unknown date, the outcome of the tingling sensation was not reported.   It was unknown if the reporter considered the tingling sensation to be related to Shingrix.  Additional details were reported as follows: The patient received the 1st dose of Shingrix. The patient experienced a prickly sensation in both arms. The patient did not experience redness or itching at the injection site until the time of reporting. The patient asked was it common. The reporter consent to follow up.
Localize warmth, (rash on chest) arm, trace papules resolved by 4/3/12.
Pt reports left arm weakness and numbness, chest pain/tightness, and overall does not feel well. does not take any medications
high fever; trembling; pain when breathing; bone pain; severe sweating; nausea; diarrhea; weakness; loss of appetite; back pain; stabbing pains in my lungs; headache; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ep6955), via an unspecified route of administration in the right arm on 23Mar2021 at 11:00 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. The patient did not have any allergies to medications, food or other products. Medical history included scleroderma and crest syndrome. Concomitant medications included losartan (MANUFACTURER UNKNOWN), carvedilol (MANUFACTURER UNKNOWN), aspirin (MANUFACTURER UNKNOWN) and isosorbide (MANUFACTURER UNKNOWN); all for unspecified indications from unknown date. The patient did not receive any other vaccines within the four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 03:00, the patient experienced high fever for 3 days, trembling, pain when breathing, bone pain, severe sweating, nausea, diarrhea, weakness, loss of appetite, back pain, stabbing pains in my lungs and headache. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported events. The clinical outcome of high fever for 3 days, trembling, pain when breathing, bone pain, severe sweating, nausea, diarrhea, weakness, loss of appetite, back pain, stabbing pains in my lungs and headache were not recovered.  No follow-up attempts are needed. No further information is expected.
Very sick; Injection site soreness; Flu like; Temperature of 101.6; Soreness; Tingling from the left shoulder down to my hand; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), PARAESTHESIA (Tingling from the left shoulder down to my hand), INFLUENZA LIKE ILLNESS (Flu like), MALAISE (Very sick) and PYREXIA (Temperature of 101.6) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     NO INFORMATION WAS ADDED.  Concurrent medical conditions included Lung cancer since 08-Feb-2016. Concomitant products included OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for Acid reflux (esophageal), SERTRALINE HYDROCHLORIDE (ZOLOFT) for Depression, INSULIN HUMAN INJECTION, ISOPHANE (NOVOLIN N) for Diabetes mellitus, HYDROCODONE for Pain, PEMBROLIZUMAB (KEYTRUDA), ZOLEDRONIC ACID (ZOMETA LIVI) and CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]) for an unknown indication.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 mg. On 19-Mar-2021, the patient experienced PAIN (Soreness) and PARAESTHESIA (Tingling from the left shoulder down to my hand). On 20-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like) and PYREXIA (Temperature of 101.6). On an unknown date, the patient experienced MALAISE (Very sick) and VACCINATION SITE PAIN (Injection site soreness). At the time of the report, PAIN (Soreness), PARAESTHESIA (Tingling from the left shoulder down to my hand), MALAISE (Very sick) and VACCINATION SITE PAIN (Injection site soreness) outcome was unknown and INFLUENZA LIKE ILLNESS (Flu like) and PYREXIA (Temperature of 101.6) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Body temperature: 101.6 (Inconclusive) Temperature of 101.6 was reported..         No treatment information was provided.   This case was linked to MOD-2021-085755 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Additional information included, medical history, laboratory data, concomitant product with indications, new event ( fever, tingling arm, feeling sick, flu like symptoms) were updated. On 26-May-2021: significant follow up
Moderna vaccine is approved for 18 years and older but we immunized this patient by mistake - he is only 17 years,  9 and a half months. I spoke with the patient and his mom and explained what happened. They will come back in 4 weeks for the second immunization. patient has not experienced any side effects so far.
Fatigue; felt like i was hit by a train; About 30 hour afterwards, scalp was itching so bad; first 4 minutes I was burning up for about 20-25 min like a hot flash; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like i was hit by a train), FATIGUE (Fatigue), BURNING SENSATION (first 4 minutes I was burning up for about 20-25 min like a hot flash) and PRURITUS (About 30 hour afterwards, scalp was itching so bad) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included AMLODIPINE for Blood pressure, OMEPRAZOLE and VITAMIN D NOS for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced BURNING SENSATION (first 4 minutes I was burning up for about 20-25 min like a hot flash). On 20-Jan-2021, the patient experienced FEELING ABNORMAL (felt like i was hit by a train) and PRURITUS (About 30 hour afterwards, scalp was itching so bad). On an unknown date, the patient experienced FATIGUE (Fatigue). On 19-Jan-2021, BURNING SENSATION (first 4 minutes I was burning up for about 20-25 min like a hot flash) had resolved. On 26-Jan-2021, PRURITUS (About 30 hour afterwards, scalp was itching so bad) had resolved. At the time of the report, FEELING ABNORMAL (felt like i was hit by a train) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
3-4 days after vaccine pt devolped DVT and PE no other known provoking factors, pt did have VTE in 2019 and was no longer on anticoagulation
Information has been received from a registered nurse concerning her daughter in her early twenties, who was diagnosed with Guillain-Barre syndrome at the age of 7. On 20-JUN-2007 the patient had her first dose of Gardasil (Lot #657868/0523U) intramuscularly, and on 06-OCT-2007 was vaccinated with her second dose of Gardasil (Lot #658560/1062U). Concomitant therapy included meningococcal vaccine (unspecified) which was also received on 06-OCT-2007. Shortly after her second dose of Gardasil her daughter displayed signs of Guillain-Barre syndrome, specifically "back pain". The patient's second dose of Gardasil was administered 4 months after her first dose. No further information was provided. Upon medical review Guillain-Barre syndrome was considered to be an other important medical event. Additional information has been requested.  12/28/07 Follow up initiated at request of CDC.  T/C to provider who stated patient did not have final dx of GBS.  Had history of GBS at 8 yrs old.  Was not hospitalized in 2007.  12/28/07 Received vax record & office record.  Gardasil #1 given 6/20/07 lot 0523U.  Menactra given 6/20/07 lot# U2231AA.  Gardasil #2 given 10/6/07 lot # 1062U.  Office vs of 10/6 was for shot only, no med record.  Next visit 10/19/07 w/neck, shoulder & back pain, since 10/6/07. Exam revealed sniffles & post nasal drip.  Week before, patient reported dysphagia which had resolved.  Dx w/viral illness & reflux.  Tx w/benadryl & prilosec.
PATIENT RECEIVED PFIZER IMMUNIZATION ON 26APR2021 AND STARTED HAVING CHEST PAIN ON 28APR2021. PATIENT WENT TO EMERGENCY ROOM AND WAS TREATED.
Patient admitted to hospital on 9/5/21 due to weakness and low back pain after receiving her Moderna COVID 19 booster on 9/1/21. Found to be dehydrated and to have viral pneumonia and be COVID positive. Received IV dexamethasone and required acute oxygen to maintain sats >90%. At discharge was no longer on O2.
I got positive a test for COVID-19, and I scheduled a virtual appointment with the doctor, and he prescribed Paxlovid. I had nausea, caught, diarrhea, shortness of breath. I took medicine and I felt fine. This is the third time I got COVID-19.
Information has been received from a physician concerning a female patient who was vaccinated with Gardasil. Subsequently the patient experienced swelling lips, jaw problem and hypertension. Additional information has been requested.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On 04-FEB-2016, the patient was received improperly stored PEDVAXHIB lot # L030870, expiration date 10-JUN-2018, 0.5 ml, intramuscularly. No adverse effects were reported. Additional information has been requested.
This spontaneous report was received from a 67 year old no pregnant female consumer referring to herself with depression, allergy to CELEBREX and LYRICA. The patient's medical history included myalgia and hormone therapy. On 08-JUN-2015, the patient was vaccinated with PNEUMOVAX 23 (lot # K007825: Exp 13-JAN-2016), intramuscular in the arm (dose was not provided). Concomitant therapies included an unspecified anti-depressant medication and unspecified hormone therapy medication. On 09-JUN-2015 (reported about 12 hours after getting the injection), the patient experienced injection site pain and her arm was swollen. The patient went from elbow to shoulder. (She took 3 ADVIL tablets, but that did not help relieve the pain). The patient also experience pyrexia that lasted four days. She experience chills, then hyperhidrosis during the four days. The patient had decreased appetite, dizziness, and was too fatigued to see her doctor. No treatment was given for the adverse events. No laboratory diagnostic test were performed. At the time of the report, the outcome of hyperhidrosis, fatigue, chills, pyrexia, injection site pain, peripheral swelling, pain in extremity, dizziness and decreased appetite was reported as recovering. Product quality compliance was not involved. Additional information has been requested.
Varicella vaccine breakthrough diagnosed with Varicella (10 lesions) on 5/24/07. No fever.
Nosebleed; arm was sore; kinda tired; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Nosebleed), PAIN IN EXTREMITY (arm was sore) and FATIGUE (kinda tired) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004CZ1A and 008B21-2A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced EPISTAXIS (Nosebleed), PAIN IN EXTREMITY (arm was sore) and FATIGUE (kinda tired). On 08-May-2021, EPISTAXIS (Nosebleed) had resolved. On 10-May-2021, FATIGUE (kinda tired) had resolved. At the time of the report, PAIN IN EXTREMITY (arm was sore) outcome was unknown.            Patient stated that after he got shot with in 6 to 10 hours, had nose bleed mentioned that he did not take anything for nosebleed,  just put pressure on it with a Kleenex and overtime it clotted  Patient also stated that he is not on any medications and does not have any health conditions. No treatment medications were provided by reporter.   This case was linked to MOD-2021-319561 (Patient Link).